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Re~u/~: K/ss~ng sSent inse~lton was successfully pedormed in el{ 20 
patlents wtthout acuto complicatlons. Mean porcent stenosls de¢reasod !rom 
462 ~ 24,8% to -6,8% -t: 13,3% (p = 0.0001) In the rlght Illtac artery, 42,3 
± 22,8% to -1.6 ~ 18,1% (p = 0,0001) in the laft !lies arten/, and 19,t 
16.6% 1o 2.3 ,t: 15,4% (p ~, 0,0008) In the distel sorte, Thero wem no doaths, 
MI'a er emergent aurgew, In!erratt!ent claudlemlon symptoms wem Improved 
In 18 of 19 patlents (g5%) wlth 12 of 19 patlents (63%) be¢omlng totaUy 
asymplomatl¢, The ùtrongest predlctor of cllnlsnt out¢ome followlng klsslng 
slant Insertlon was the pro,procodural axtsnt et femoropopltteal dsease: 
5g% et pt~tlanta wlth temoropopl~leal narrowlng ,~75% bllateratty bekäme 
¢omptetely asymptomRtl¢ ~tt follow,up ¢omp~md wlth only 30% of patlonts 
wlth mofa aevere mnoseß (p =~ 0,0~), 
Con~luslon: $tanonos of the ~~ortlo blfum~tlon sch be tro~tad eff~ttvaty 
wlth kl~t~leg atont~ w(thout ~ny immadt~ta adverbs outcomea, 
Prophet!l© Festere end au!satan In Haart 
Fallum 
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~ Pmdlctora of 1 Yur Mortallty In 2086 Outpatlentu 
Wllh Conoeatlvo Haart Fallum: Datn Fmm llallan 
Network on Congelt lve Hanf! Fallum 
AP, Magglont, L, Di Grauer!o, M, Gortni, P, Midi, D, Lu¢oi, L, '~tva~~l, On 
b~h,~tf of fN,CHF fnvpstif)atom, ANMCO Re~~'lrch C~ntar, Ffomnc~, ffaly 
l~ekgroond: Pharmacologl¢at tm~tment~ Ot patl~nta wtth congoslive heart 
tatlum (GHF) am gm~tly changed in the t~st 5 yeam, due te the favourable 
maulte ~howod by savaral, weil ¢ol~ducted ¢ontmllnd ellntoRI studios, How- 
avor, tow data am avall~bla on lho out¢ome ~! pallents lma!ed at the bast ot 
the recommendad troatments, Further, apostel atfentlon should be given to 
1ha ¢linlcal pr~tlQtors of doath la tmprovo pattonts urvlvaL 
M~ftm~s: Wo pro~po¢tNely follownd 2086 pattents, onmlled in the CHF 
Italien Network pmjo¢l, In!ormatlon on 1 yaar follow-up ware collectod by 
Iocally tmlnod cllnI¢lans ustng on ad-hoc soltv, aro, Unlvarlate and multivari- 
ate analyses wem pedormnd le ovaluR1e the associntion betwoea clintcN 
variables and 1 yoar mortatity, 
Rasur!s: ans year modaltty was 22,9% (479/2086) desplto the high rate 
of usa et recommended troatmonls: ACEqnhibltors 81%, digitalls 70%, di- 
umttcs 87%. Betnblockors wem used in only 9% et pts, Mul!ivadato analysis, 
adluslod for the main clinicat-epidomtotogtcat v nabtes howed !hat the tel- 
lawine variables wem stgn[[icnntly associatod with e higher 1 yonr morlaMy: 
age (~70 vs <70 yoars) (eR 1,73 95% CI 1.35-2.22), NYHA class (qI-W 
vs I-tl) (eR 1.87 95% CI 1,48-2.36), at least 1 vs no hospitat admsssion 
~n the year procoding the ente/ visd (eR 1.66 95% CI 1,30-2.11), staat 
flutter/libfltlalton vs sln~,~s rhylhm (eR 1.33 95% CI 1,01-1,75), prosence 
vs absenco o1 thtrd haart sound (eR 1.47 95% CI 1.15-1,87), cmatinine 
level (-2.5 vs ~2,5) (eR 4,33 95% C[ 1.79-10.44), pts not tmatod with 
ACE,Inhlbltors vs pts on ACE !ma!ment (eR 1,41 95% CI 1.07-187), 
Conctusions: Our study shows !hat 1 year mortality el outpatients with 
CHF, toflowod by cardlologtsts, is still high despite the high comptiance to 
treatments guidelines. Simple clinieal-epidemiologicat v riables can identily 
high risk pts to whom spocilic tnterventions to improve suwival should be 
targetett 
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[ " f f~-~ CIInl¢al Chara¢terlstl¢s and Long-term Outcomes of 
Patlents Wlth Diastollc Heart Failure 
C,M. O'Connor, L,K, Shaw, D,J. Whollan, C,H. Uel Code, R.L. Lassen, 
W,A, Galtis, M.$. Cuffo, R,M. Califl, Duke University Mad!aal Center, 
Durham, NG USA 
13ackgrouncl: AIthough the syndrome of dies!alis haart faitum (DHF) may 
oCcur in up to 40% of ad heer! failure patients (pts), the clinical, angiographic 
characteristics, and Iong-term outcomes of these pts is poorly understood. 
Methode: We prospoctively evaluated 3,498 consecutive pts with New 
York Haart Association class II-IV symptoms and ejec~ion fractions (EF) 
>0.40, who undenNent cardiac catheterizat!on between 1/84-12/96 at Duke 
University Medicat Center. 
Resu/ts: Tl~e medien age for the entire cohort was 64 years, 25% of the 
populetion was over the age of 70. In addition, 55% of the pts wem of female 
gender, 60% had ischemic haart d(sease, 26% had a history of diabetes, 
59% had a history of hypertension, and 11% had moderate valvular haart 
disease (VHD). The medien EF was 58%. One third of the pts had multivessel 
disease by coronary angiography. 
The 5 year mortality was 0.34 in the ischemic cohort, and 0.26 in the 
nonlschomlc ohorL The (ncraponctent pre¢/icfors of morta(ity (p < 0,05) us!ne 
a muttlvarlable Cox proportional hazard modal wem ege, Class IV symptoms, 
absence of angintt VHD, ex!ent nf nomnary disease, poripheral vascular 
dlssase, Iower EF, diabetes mellttus, and mtnofity rase. 
Conc/usion: DHF la chamcterlzod by unlque clintcal and angiographi¢ 
charactorlstlcs assoclated wllh a 5 year mortatity rate et 0.31, Furtbermom, 
sevoml ¢linlcal and nnglogmphl¢ sharacterlsUes am predl¢tlvo f IOl~l,tefm 
auwlvaL 
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~ Prognosls of Haart Fallum- A Populltlon.bned 
8tudy of the Out©oma In Inoldent Oase= 
M,R, Cowla, V, Sùmsh, D_,A, Wood, A,J, Co~ta, S,G, Thompson, 
P,A, Poolo,Wdson, G.C, Station, HtllingdPn Hosplt~t, Uxb#dge M~~tx U.K 
lmpori~l Coll(~go School of Mcdlcine, London, UK 
Backgmllncl: Them la no inlorma!ion on the outcoma of inc!den! ¢'ase~, of 
heer f(~ilgm artsieg !mm the ganaml poptll~tian, Them is ~n a~sumption that 
the plocobo arm of c!inic~ti !aals whi(:h involve l~tients with beart fai!um o! 
dilfsmnt savorlty pmvides a~qmla inlorm~ticm on prognosis, 
Me3t~d~; The pm~e_nt s.tgdy anml!ed 2L~ i~ident aases el hearl lot!um el 
any I~ge !mm a popu!aliOn o! 150,000 poopte in wem London Over a 20 month 
period, C~ses wem tdanlifiad !mm a(~ute admisstons to the hosPita! sennng 
lhls poptdation (82%) and fmm a rapid,a~ess c!inic; (18'%) 1o wisch any sus, 
pectnd caso et haart tailgm could 13o mterrod. The clin|ca! assQssm(~t, ECG, 
chest x-ray and echocardiogram et all aases wem subsequently revù~~e«l by 
a panel Ot threo c,ar'diotogists working to a pre-set definitKm of bearl tailum 
according 1o the guidelines of the Eumpean Society (:il CardK~logy. 
Resufts: Tba aeries tnclùded 118 men and 102 weinen wdh a median age 
el 76 years, With an ava,~ge fol!ow-up of 16 men!bs, them wem 90 deaths, 
83 due 1o ~aTdiovascular diseese and 7 !mm neoplastic disease. Sun,,ival was 
81% at ono monlh, 7!% at 6 months and 64% at orte year. Co~ unntanate 
analysis showed many retters including NYHA class, cardiothoracic rat=o. 
aad degrtm at Dulmonan/congostioe on chest ~,ray 1o be assoctated wtlh 
~untival, Patients wlth atoal fibrillatioa (pamxysma! er established) had a 
bot!er prr~..nosis 1hen !base in staus rhythm. Multtvanate analysis showed 
that age, systolic btoOd pressure, rates, and serum area!in!ne levels (re!lee!tag 
the hemodynamic severity oi the presentation) wem signitsantty assooated 
with survivaL Etiology of haart ladure was ast asses!sied with prognosis. 
Conclusion.~: Them am stnking diffemnces between the tme populatton 
of hearl laib, re pationts and these enrotled in clinical trials. The suwivet c! 
incident cases is paar, particulady dunng the first month alter presentation 
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~ Incldence, Predtctlve Fastete and Prognostic 
Signlficance of Supraventricular "l~achyarrhythmias 
In Congestlve Heart FaUure 
J, Mathew, S. Hunsberger, J, Fleg, F. Mc Sherry, W. Wdliford, $. Yusuf. For 
the Oigitatis Investigatton Group, Cook CounIF Hospital, Chicago. Ilhnols 
and the National Heart Lung and Btood Institute, Bethesda, Maryland. USA 
Background: The incidence, the prodictive iactors and the morbidity and mor- 
tality associated with the development o! supravenlticutar tachyarrhylhmias 
(SVT) in patients with congestive heart failure (CHF) ere poody undemtood 
We examined these questions in the data !rom the Dtgitalis Investigation 
Group (OLG) trial. 
Methods: In the OlG tnat, patients with CHF who wem in sinus rhythm wem 
randomty assignod to digoxin (n = 3889) er placebo (n = 3899) and fol~owed 
for a mean of 37 months. Baseline factors the! predicted the occurrence 
of SVT wem determined by Iogistic regression analysis. Cox proportional 
hazard model was used to determine the effect el SVT on total mortelity and 
stroke. 
Results: Eight hundred sixty-six patients (11,1%) developed SVT dunng 
the study per!od. Older age [odds ra!is (eR) 1.029, p = 0.0001], male gender 
(eR 1.258, p = 0,01) increasing duration of CHF (eR 1.003, p = 0.002) and a 
cardio-thoracic ra!is of :-0.50 (eR 1.416, p = 0.0001) predicted an incmased 
risk of developing SVT. Left ventncular ejection trost!on, New York Haart 
Asses!arien Functional Class and !ma!ment with digoxin versus placebo 
ware not rolated to the oceurrence o! SVT. Alter adjustment for these other 
risk factors, developmcnt of SVT predicted a greater risk of total mortality 
(Risk Ratio (RR) = 2,453, p = 0.0001), and stroke (RR = 2.379, p = 0.0001). 
Conclusion: In a population with CHF, older age, male gender, langer 
duration of CHF and increased cardio-thoracic ratte predict an increased risk 
for developing SVT which, in turn, is a streng independent risk factor for 
stroko and mortality in this populetion. 
